AI
VYGR icon

Atom Investors’s Voyager Therapeutics VYGR Stock Holding History

Atom Investors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,083
Closed -$117K – 558
2023
Q3 		$117K Buy
+15,083
New +$138K 0.03% 404

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Atom Investors's VYGR Position: Q4 2023 in Review

Atom Investors sold out of Voyager Therapeutics (VYGR) in Q4 2023, closing a stake of 15,083 shares — an estimated $117K sold.

Atom Investors first reported a position in VYGR in Q3 2023 and held it in 1 quarter. The position peaked at $117K in Q3 2023. 107 funds tracked by Wall St. Rank hold VYGR as of Q4 2023.

  • Atom Investors reported no remaining Voyager Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Atom Investors sold 15,083 Voyager Therapeutics shares in Q4 2023, an estimated $117K.
  • Atom Investors first reported a position in Voyager Therapeutics in Q3 2023 and held it in 1 quarter.
  • Atom Investors's Voyager Therapeutics position peaked at $117K in Q3 2023.
  • 107 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2023.

Based on Atom Investors's 13F filing for Q4 2023, filed 14 Feb 2024.